This study investigated follicular development during and after postweaning altrenogest treatment of primiparous sows in relation to subsequent reproductive performance. Primiparous sows (n = 259) were randomly assigned at weaning (d 0) to 1 of 4 groups: control (no altrenogest, n = 71), RU4 (20 mg of altrenogest from d -1 to 2, n = 62), RU8 (20 mg of altrenogest from d -1 to 6, n = 65), or RU15 (20 mg of altrenogest from d -1 to 13, n = 61). Average follicular size (measured by ultrasound) increased during altrenogest treatment and resulted in larger follicles at the start of the follicular phase for RU4, RU8, and RU15 compared with controls (5.3 ± 0.9, 5.5 ± 1.3, 5.1 ± 1.2, and 3.4 ± 0.6 mm, respectively; P < 0.0001). Farrowing rate was greater in RU15 (95%) than in RU8 (76%; P = 0.04). The RU15 group also had more piglets (2 to 3 more piglets total born and born alive; P < 0.05) than the other treatment groups. Follicular development at weaning clearly affected reproductive performance. At weaning, average follicular size: small (<3.5 mm), medium (3.5 to 4.5 mm), or large (≥ 4.5 mm), was associated with farrowing rates of 86, 78, and 48%, respectively (P < 0.001). Sows with large follicles at weaning had low farrowing rates (71%) in RU4, very low farrowing rates (22%) in RU8, but normal farrowing rates in RU15 (83%). In conclusion, this study showed that 15 d of postweaning altrenogest treatment of primiparous sows may allow follicle turnover in sows that had large follicles at weaning and that this was associated with an improved reproductive performance. It also showed that shorter treatment with altrenogest (4 or 8 d) is beneficial for sows with small follicles at weaning, but is not recommendable for sows with large follicles at weaning.

Staphylococcus aureus is a common colonizer in pigs, with methicillin-resistant S. aureus (MRSA) in particular being a potential health risk to humans. To reduce the exposure to humans, the colonization in pigs should be reduced. The aim of this study was to quantitatively compare the susceptibility of pig lineages for S. aureus colonization, and if the absence of S. aureus could be associated with the presence or absence of other staphylococcal species. Nasal samples (n = 129) were obtained from seven different pig lineages in the Netherlands, France, and Germany. S. aureus and other staphylococci were enumerated from these samples by real-time (RT)-PCR and culture. Associations were explored between the presence of S. aureus and other staphylococci. S. aureus was detected by RT-PCR on all farms and in samples from pigs of all lineages. Twenty-five percent of the pigs from lineage F (from two farms) were colonized with S. aureus, while in all other lineages it was more than 50% (p < 0.01). Moreover, in S. aureus-positive samples from pigs of lineage F smaller amounts of S. aureus were found than in other lineages. Staphylococcus sciuri, Staphylococcus cohnii, and Staphylococcus saprophyticus were usually not found in combination with S. aureus in these samples. In conclusion: (i) pigs from different genetic lineages have different susceptibilities for colonization with S. aureus. These pigs might contain a genetic factor influencing nasal colonization. (ii) Colonization of S. aureus is also associated with the absence of S. sciuri, S. cohnii, or S. saprophyticus. (iii) The farm environment seems to influence the presence of S. aureus in pigs.

No abstract

In a previous study, we showed that follicle size at weaning affects the response of a sow to a short-term altrenogest treatment after weaning. In this study, an attempt was made to prevent the growth of follicles into larger size categories before weaning by using different altrenogest treatments before weaning to improve reproductive performance after postweaning altrenogest treatments. Sows (87 primiparous and 130 multiparous) were assigned to the following treatments: control (no altrenogest treatment; n=59), RU0-20 (20 mg of altrenogest from d -1 to 6; weaning=d 0; n=53), RU40-20 (40 mg of altrenogest from d -3 to 0 and 20 mg of altrenogest from d 1 to 6; n=53), and RU20-20 (20 mg of altrenogest from d -3 to 6; n=52). Follicle size was assessed daily with transabdominal ultrasound. Follicle sizes on d -3 (3.6 ± 0.7 mm) and at weaning (4.0 ± 0.7 mm) were similar for all treatments. Altrenogest-treated sows had larger follicles at the beginning of the follicular phase than did control sows [5.4 ± 0.1 and 3.8 ± 0.2 mm (least squares means), respectively; P < 0.0001] and on d 4 of the follicular phase [8.0 ± 0.1 and 6.7 ± 0.2 mm (least squares means), respectively; P < 0.0001]. Multiparous sows had larger follicles than did primiparous sows at the beginning of the follicular phase [5.3 ± 0.1 and 4.7 ± 0.1 mm (least squares means), respectively; P < 0.01] and on d 4 of the follicular phase [8.0 ± 0.1 and 7.0 ± 0.1 mm (least squares means), respectively; P < 0.0001]. Farrowing rate and litter size (born alive + dead) were not affected by treatment or parity. However, in primiparous sows, when mummies were included in litter size, altrenogest-treated sows had larger litters than did control sows (13.4 ± 0.5 and 11.9 ± 0.7 piglets, respectively; P=0.02). In primiparous control sows, backfat depth at weaning and litter size were positively related (slope of the regression line=0.82; P < 0.05), which was not the case in primiparous sows receiving altrenogest. In conclusion, the different altrenogest treatments before weaning did not prevent the growth of follicles before weaning and similarly affected subsequent follicle development and fertility. In primiparous sows, altrenogest treatment after weaning increased the number of fetuses during pregnancy, but positive effects seemed limited by uterine capacity. Altrenogest treatment after weaning improved litter size in primiparous sows with reduced backfat depth at weaning, which suggests a specific positive effect of a recovery period after weaning in sows with reduced BCS at weaning.

This study investigated the endocrine background of follicle size changes during post-weaning altrenogest treatment. altrenogest-treated sows received a 20-mg dosage daily at 8.00 a.m. from Day -1 to Day 14 after weaning. On Day -1, only 3/13 altrenogest-treated sows showed LH pulses compared with 8/8 control sows (P=0.001). On Day 0, control sows showed a typical high frequency-low amplitude LH pattern, indicative for recruitment of oestrogenic follicles. In altrenogest-treated animals on Day 0, half of the sows showed high frequency-high amplitude pulses from 4-5h after weaning. In altrenogest-treated sows, average follicle size increased from 3.1±0.5 mm on Day 0 to 4.4±0.6mm on Day 5, then decreased to 3.7±0.5 mm on Day 7 and stabilised thereafter. FSH and oestradiol (E2) concentrations showed a distinct diurnal pattern; high at 7.00 a.m. and low at 3.00 p.m. E2 concentrations (7.00 a.m.) showed a 2.5-fold increase from Day -1 to Day 2, and subsequently a 2-fold decline to reach a plateau at Day 8. FSH concentrations reached maximum levels by Day 5 and slowly declined afterwards. In conclusion, once-daily administration of altrenogest starting one day before weaning delays the weaning-induced increase in LH pulses. Although FSH and follicle size increase until Day 5 after weaning, follicle E2 production already decreased from Day 2 after weaning. Post-weaning altrenogest treatment thus results in a follicular wave of follicles that lose oestrogenic competence at Day 2 after weaning, presumably related to the changed LH dynamics during altrenogest treatment.